Renovo Group Plc
| London Stock Exchange: RNVO
Renovo Group Plc is a biopharmaceutical company, which engages in discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration. The company has a portfolio of clinical programmes including potential pharmaceutical drugs to reduce scarring, human recombinant interleukin, embryonic wounds, enhance wound healing, and digital flexor tendons. Its products are Juvista, Juvidex, Prevascar, and Adaprev. Renovo Group was founded by Mark William James Ferguson and Sharon O'Kane in 1998 and is headquartered in Manchester, the United Kingdom.